ABT - ABBOTT LABORATORIES
133.24
-0.760 -0.570%
Share volume: 4,976,167
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$134.00
-0.76
-0.01%
Summary score
66%
Profitability
71%
Dept financing
39%
Liquidity
75%
Performance
66%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
5.06%
Return on assets
2.6%
Return on sales
17.43%
Return on invested capital
4.66%
Total debt ratio
48.71%
Debt ratio change over timeo
10.98%
Current Ratio
1.74%
Quick Ratio
1.28%
Cash Position Ratio
0.6%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.44%
Return on sales
16.83%
Return on invested capital
0%
Total debt ratio
43.54%
Debt ratio change over timeo
0%
Current Ratio
1.68%
Quick Ratio
1.21%
Cash Position Ratio
0.51%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.24%
Return on sales
16.34%
Return on invested capital
0%
Total debt ratio
40.07%
Debt ratio change over time
0%
Current Ratio
1.78%
Quick Ratio
1.27%
Cash Position Ratio
0.5%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
23.23%
Return on assets
-28.88%
Return on sales
368.28%
Return on invested capital
13.41%
Total debt ratio
1097.51%
Debt ratio change over time
10.98%
Current Ratio
40.29%
Quick Ratio
30.81%
Cash Position Ratio
15.2%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 5.06% | 14.28% | 9.23% | 0% |
| Return on assets | 2.6% | 4.23% | 3.2% | 0% |
| Return on sales | 17.43% | 27.89% | 25.03% | 0% |
| Return on invested capital | 4.66% | 8.36% | 9.37% | 0% |
| Profitability | 52% | 97% | 83% | 0% |
| Total debt ratio | 48.71% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 10.98% | -11.36% | -57.43% | 0% |
| Dept financing | 40% | 25% | 18% | 0% |
| Current Ratio | 1.68% | 1.23% | 1.12% | 0% |
| Quick Ratio | 1.21% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.51% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 42% | 60% | 0% |
| Short-term ratios | ABT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 2.44% | 4.32% | 3.49% | 0% |
| Return on sales | 16.83% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 79% | 50% | 41% | 0% |
| Total debt ratio | 43.54% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 38% | 25% | 18% | 0% |
| Current Ratio | 1.68% | 1.23% | 1.12% | 0% |
| Quick Ratio | 1.21% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.51% | 0.12% | 0.5% | 0% |
| Liquididy | 75% | 44% | 59% | 0% |
